Compare BioNano Genomics Inc (BNGO) vs ConocoPhillips (COP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs ConocoPhillips — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while ConocoPhillips trades at $124.71 (market cap $151.27B). The key difference: ConocoPhillips is far larger — about 11073.9× BioNano Genomics Inc's market cap, and ConocoPhillips pays a 2.67% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | COP | |
|---|---|---|
Market Cap | $13.66M | $151.27B |
Sector | Health | Energy |
52-Week High | $4.92 | $133.80 |
52-Week Low | $1.06 | $85.66 |
Enterprise Value | $16.26M | $166.87B |
Dividend Yield | — | 2.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →
